News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for December 2020 Shelley Wood December 31, 2020
News Daily News William R. Hiatt, Giant of Vascular Medicine, Dies at 70 L.A. McKeown December 11, 2020
News Conference News ESC 2020 VOYAGER PAD: CAD Subanalysis Finds Fewer CV, Limb Events With Rivaroxaban L.A. McKeown September 03, 2020
News Conference News ACC 2020 New Questions About Triple Therapy After PAD Revascularization: VOYAGER PAD Substudy L.A. McKeown April 02, 2020
Presentation ACC 2020 VOYAGER PAD Efficacy and Safety of Rivaroxaban in Patients with Symptomatic PAD undergoing Revascularization with and without Clopidogrel Presenter: William Hiatt March 29, 2020
News Daily News Outcome Differences Between Men and Women With PAD: EUCLID Insights L.A. McKeown February 11, 2020
News Daily News Which ASCVD Patients Will Benefit Most From Rivaroxaban Plus Aspirin? Some Clues Todd Neale June 26, 2019
News Daily News Most PAD Patients ‘Dramatically Undertreated’ With Preventive Meds, Lifestyle Counseling L.A. McKeown May 01, 2017